ConvaTec Group (CTEC) Rating Reiterated by Peel Hunt
ConvaTec Group (LON:CTEC)‘s stock had its “hold” rating reiterated by stock analysts at Peel Hunt in a research report issued to clients and investors on Tuesday.
Several other research analysts have also recently commented on the company. Goldman Sachs Group reduced their target price on ConvaTec Group from GBX 160 ($2.09) to GBX 118 ($1.54) and set a “neutral” rating for the company in a research report on Tuesday, February 19th. UBS Group reduced their target price on ConvaTec Group from GBX 150 ($1.96) to GBX 120 ($1.57) and set a “neutral” rating for the company in a research report on Tuesday, February 19th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a GBX 135 ($1.76) target price (down from GBX 192 ($2.51)) on shares of ConvaTec Group in a research report on Monday, February 18th. Barclays reduced their target price on ConvaTec Group from GBX 150 ($1.96) to GBX 148 ($1.93) and set an “underweight” rating for the company in a research report on Friday, February 8th. Finally, Numis Securities reaffirmed a “buy” rating and issued a GBX 220 ($2.87) target price on shares of ConvaTec Group in a research report on Monday, January 21st. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of GBX 173.09 ($2.26).
Shares of CTEC stock opened at GBX 134 ($1.75) on Tuesday. ConvaTec Group has a one year low of GBX 181.40 ($2.37) and a one year high of GBX 349.10 ($4.56).
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Further Reading: What is the outlook for the FAANG stocks?
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.